Association between low bone mineral density (BMD) and ischemic heart disease (IHD) remains challenging. According to some recent evidence, osteoporotic patients not only face bone fracture, but also may be exposed to increased risk for brain stroke, cognitive disorders, arterial atherosclerosis, and even cardiac-related death in both men and women (
1-
5). However, the explaining reasons for this relationship remain unknown. Due to some common risk factors for both atherosclerosis and osteoporosis such as smoking, systemic inflammatory conditions, or postmenopausal status, common pathophysiological pathways for these two clinical conditions are expectable (
6-
9). For instance, postmenopausal osteoporotic women significantly face a higher risk for IHD compared to other age subgroups of women (
10-
12).
One of the main causes of osteoporosis is vitamin D deficiency frequently due to inadequate sun exposure, low dietary intake, low physical activity, or air pollution (
11,
12). It has been well shown that vitamin D deficiency may have deleterious effects on cardiovascular system (
13-
15). Vitamin D receptors are widely distributed in different tissues including smooth muscles of vessels, endothelium, and also cardiomyocytes. In vivo study could reveal that 25-hydroxy vitamin D may directly inhibit expression of genes related to smooth muscle proliferation and cardiomyocytes as well as inhibit secretion of cytokines from lymphocytes (
16-
18). Also, some experimental studies on animal models show that lack of vitamin D receptor activators can result in hypertension, and left ventricular hypertrophy (
19). Moreover, vitamin D deficiency may be accompanied by an increased level of parathyroid hormone leading to insulin resistance that is a major cause of diabetes mellitus, activation of inflammatory processes as well as coronary atherosclerosis (
20-
22). Because of the increasing trend of vitamin D deficiency and also osteoporosis, it is vital to clarify the association between IHD and vitamin D deficiency.